Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novartis Oncology announces Glivec name change in U.S.

May 3, 2001

Nonestrogenic steroid sulfatase inhibitors identified at Jenapharm

May 2, 2001

Water-soluble prodrug prepared to overcome clinical limitations of quercetin

May 2, 2001

CASB6411 polypeptides and polynucleotides and use in cancer treatment, diagnosis

May 2, 2001

Inex and Elan form joint venture to develop and commercialize Onco TCS

May 2, 2001

Small-molecule dual alphavbeta3/alphavbeta5 integrin inhibitor Sch-221153 inhibits angiogenesis

May 2, 2001

Novogen creates new company to develop phenoxodiol

May 2, 2001

LEraf-AON, a liposomal antisense oligodeoxyribonucleotide for enhancing radiation effects

May 2, 2001

Myriad Genetics' MPC-7869 stabilizes PSA levels in phase II

May 2, 2001

Lilly claims new use of parathyroid hormone

April 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...